Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0000899243-19-026927
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2019-11-08 12:26:13
Reporting Period:
2019-09-27
Accepted Time:
2019-11-08 12:26:13
Original Submission Date:
2019-10-02
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1415684 Musclepharm Corp MSLP () 4/A
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1008190 Mark Blundell Co White Winston Select Asset Funds, Llc
265 Franklin St., Suite 1702
Boston MA 02110
No No Yes No
1559652 P Robert Mahoney Co White Winston Select Asset Funds, Llc
265 Franklin St., Suite 1702
Boston MA 02110
No No Yes No
1647702 M. Todd Enright Co White Winston Select Asset Funds, Llc
265 Franklin St., Suite 1702
Boston MA 02110
No No Yes No
1647837 Donald Feagan Co White Winston Select Asset Funds, Llc
265 Franklin St., Suite 1702
Boston MA 02110
No No Yes No
1647840 White Winston Select Asset Funds, Llc 265 Franklin St., Suite 1702
Boston MA 02110
No No Yes No
1738154 White Winston Select Asset Fund Series Fund Mp-18, Llc 265 Franklin St., Suite 1702
Boston MA 02115
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-09-30 626,826 $0.00 3,648,355 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. This Form 4 amends a Form 4 filed by the reporting person on October 2, 2019, which erroneously reported in Table I, Column 5 that the amount of securities beneficially owned following the reported transaction was 3,658,180, rather than 3,648,355.